David Ian Bell

David Ian Bell

Directeur/Membre du Conseil chez BIOTEST GMBH & CO. KGAA

Fortune : 228 417 $ au 31/08/2026

72 ans
Health Technology
Commercial Services
Consumer Services

Profil

David Ian Bell is currently Chief Executive Officer at Biomat USA, Inc., Chief Executive Officer at Grifols Bio Supplies, Inc., President & Chief Executive Officer at Grifols Innovation & New Technologies Ltd., President & Director at Alkahest, Inc., Director at Plasma Protein Therapeutics Association since 2020, Director at BPC Plasma, Inc., Director at Theriva Biologics SL, Director at GigaGen, Inc., Chief Corporate Affairs & Legal Officer at Grifols SA since 2003, Member-Supervisory Board at Biotest GmbH & Co. KGaA since 2022, and Vice President-Corporate Operations & Development at Grifols USA, Inc. since 2013.
Former roles include Director at Aradigm Corp.
from 2013 to 2018, Director at Shanghai RAAS Blood Products Co., Ltd., Director at Singulex, Inc., Vice President-Operations & Development at Grifols, Inc., Member of the California State Bar Association, Secretary, Vice President & General Counsel at Alpha Therapeutic Corp.
from 2000 to 2003, and Partner at Knapp, Petersen & Clarke PC from 1981 to 2000.
Education includes undergraduate degree from the University of California, Irvine in 1975 and graduate degree from Southwestern Law School in 1978.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
17/04/2026 20 000 ( 0% ) 228 417 $ 31/08/2026

Postes actifs de David Ian Bell

SociétésPosteDébut
GRIFOLS, S.A. Conseiller Juridique Général 01/07/2003
BIOTEST GMBH & CO. KGAA Directeur/Membre du Conseil 01/06/2022
Conseiller Juridique Général 01/07/2003
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
President -
Directeur/Membre du Conseil -
Directeur Général -
Directeur Général -
░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░

Anciens postes connus de David Ian Bell

SociétésPosteFin
░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░ -
Voir l'expérience en détail de David Ian Bell

Formation de David Ian Bell

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées20

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

California State Bar Association

Health Technology

Health Services

Health Technology

Commercial Services

Commercial Services

Commercial Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. David Ian Bell
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT